Andreas Sailer

Head Search & Evaluation TAx and White Space

Novartis Institutes for BioMedical Research Basel

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Microbiology Microbiology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andreas Sailer is the Head of Search & Evaluation at Novartis Institutes for BioMedical Research in Basel, Switzerland. His research areas include the roles of kinases in cellular signaling, protein signatures in hepatic conditions, and the involvement of gut microbiota in metabolic processes. He has contributed to various studies, including investigations into LATS kinase inhibitors and their effects on stem cells, as well as the upregulation of Ebi2 in oligodendrocytes. His work also explores the impact of gut-inhabiting Clostridia on human GPCR ligands and the role of GPR183 in inflammatory bowel diseases.

Articles (7)

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Antoine de Weck

Children's Cancer Institute Australia

AUSTRALIA

View details

Bostjan Humar

University Hospital of Zurich

SWITZERLAND

View details

Rafael Bañares

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Jan Tchorz

Professor, Director

University of Tübingen

GERMANY

View details

Tianliang Sun

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Aleksandra Rutkowska

Neuroscientist, Assistant Professor

Medical University of Gdansk

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Sailer

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo.

Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.

EBI2 Is Temporarily Upregulated in MO3.13 Oligodendrocytes during Maturation and Regulates Remyelination in the Organotypic Cerebellar Slice Model

ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation

Gut-inhabiting Clostridia build human GPCR ligands by conjugating neurotransmitters with diet- and human-derived fatty acids

Publisher Correction: Gut-inhabiting Clostridia build human GPCR ligands by conjugating neurotransmitters with diet- and human-derived fatty acids (Nature Microbiology, (2021), 6, 6, (792-805), 10.1038/s41564-021-00887-y)

The oxysterol receptor GPR183 in inflammatory bowel diseases

Collaborators (6)

Antoine de Weck

Bostjan Humar

Rafael Bañares

Jan Tchorz

Tianliang Sun

Aleksandra Rutkowska

Make your next move.